Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
ORCID: 0000-0002-3286-4888
21 - 24 out of 24Page size: 10
- Published
Shadow health records meet new data privacy laws
Price II, W. N., Spector-Bagdady, K., Minssen, Timo & Kaminski, M., 1 Feb 2019, In: Science. 363, 6426, p. 448-450 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Legal Dimensions of Big Data, Artificial Intelligence and Machine Learning in Pharmaceutical Innovation (original title in accepted version): Editorial to special issue of the European Pharmaceutical Law Review on "Big Data, AI & Machine Learning in Pharmaceutial Innovation"
Minssen, Timo & Seitz, C., 2019, In: European Pharmaceutical Law Review. 3, 4, p. 139-141 3 p.Research output: Contribution to journal › Editorial › Research
- Published
The problem with antibiotics
Darrow, J. & Minssen, Timo, May 2019, In: The Economist. 431, 9144, p. 20 1 p.Research output: Contribution to journal › Letter › Research
- Published
What lurks in the shadows of the openness hyperbole for biopharmaceuticals?
Rajam, N. & Minssen, Timo, 11 May 2019, In: Drug Development Research. 80, 3, p. 282-284 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2191
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published